Steven Artandi, MD, PhD
@SCIDirector
Followers
4K
Following
1K
Media
894
Statuses
2K
Stanford University medical oncologist and cancer scientist, and Director of the Stanford Cancer Institute. Follows and retweets are not endorsements.
Stanford, CA
Joined November 2018
I'm now on BlueSky! I look forward to continuing the conversation on the latest Stanford #CancerResearch with you there. Join me: #StanfordCancer
0
0
6
Connect with me on LinkedIn for insights on our achievements, events, and gatherings at the Stanford Cancer Institute. #StanfordCancer
0
0
8
In a systematic review and meta-analysis SCI member Eleni Linos & team found that clinicians benefit from #AI assistance in #SkinCancer diagnosis regardless of their experience level. @linos_eleni
0
0
3
SCI member @johnleppert & others found that overtreatment of low-risk #ProstateCancer with surgery or radiotherapy < while overtreatment of men with limited life expectancy and intermediate- or high-risk disease >, mainly with radiotherapy.
0
1
3
Training patient advocates is a crucial step in ensuring that patient voices are heard in cancer research. @GoldmanRosas @cncurtis.
Cancer research is being redefined by trained patient advocates who ensure patient voices guide treatment, trials, and outcomes for better care and equity. #WorldCancerDay @StanfordMed
0
0
1
SCI members @LabDfelsher, George Fisher & others found that 3 gastrointestinal #adenocarcinomas possess substantially different OS that appears differentially associated with HER2 status, mutp53, mutKRAS and MYC amplification. #GI25.
0
0
6
The microbiota modulates immune responses and influences cellular cancer therapies like hematopoietic cell transplantation and CAR T-cell therapy. SCI member @MelodySmithMD explores the mechanisms behind these interactions and future research directions.
0
0
5
SCI member Dimitrios Colevas & others found VK-2019 demonstrated an acceptable safety profile, achieved micromolar plasma concentrations, and showed on-target biological activity in tumors from patients with advanced EBV-positive #NasopharyngealCarcinoma.
0
0
1
The field of oncology has been completely transformed from where it was 15 years ago — it’s almost like science fiction now.
Lighting up hidden tumors with glowing dye, tricking cancer cells to self-destruct, rallying immune cells to rout malignancies – these are a few of the innovations of Stanford Cancer Institute members are using to tackle cancer.
0
0
3
The Stanford Cancer Institute is continually building on its rich history of innovation and excellence to redefine the limits of what’s possible in cancer care.
The latest issue of Stanford Medicine magazine explores advances in cancer science, prevention and care.
1
0
2
Stanford researchers found higher suicide deaths among cancer patients who did not undergo surgery. @AllisonKurian @linos_eleni
0
0
2
SCI member @cncurtis & others found #BreastCancer spans three genomic archetypes: ER+ high-risk tumors with complex amplifications (ecDNA), HRD-like TNBC, and stable ER+ typical-risk tumors. These suggest new treatment targets, like PARP inhibitors.
0
5
19
SCI member John Leppert & others found a potential link between certain #pesticides and increased prostate cancer incidence and mortality. @johnleppert
0
1
3
Many tumors need more copper than healthy cells to grow. SCI member Jianghong Rao & others have developed a novel method to remove copper from tumor cells, effectively killing them.
0
0
1
Congratulations to Helen Blau for receiving the 2025 National Medal of Science.
Congratulations to SCI member Helen Blau, who President Biden awarded the #NationalMedalofScience at the @WhiteHouse for her groundbreaking work on #CellularPlasticity! @POTUS
0
0
5
Please join SCI leader @Qle_stanford and colleagues at the #AACRradiation25 Conference on Translating Targeted Therapies in Combination with Radiotherapy (January 26-29). @AACR @SJD956 @max_diehn.
0
0
1
SCI member James Zou & others have found 776 genomic alterations linked to survival outcomes across 20 cancer types with specific immunotherapies, chemotherapies, or targeted therapies. #PrecisionOncology
0
0
0
SCI member Ruijiang Li & team developed an AI model with visual & language data. Trained on 50M images and 1B pathology texts, it outperformed traditional methods in predicting cancer, identifying immunotherapy candidates, & spotting recurrence risks.
0
0
2
SCI member @Qle_stanford & colleagues found gold-siRNA supraclusters enhance tumor response to #StereotacticRadiotherapy by combining radiosensitization with #immunecheckpoint silencing. They promote immune activation & reduce immunosuppressive cells.
0
0
3
Stanford's @Shawheen_Rezaei & others found veterans have higher odds of having a #SkinCancer history compared with nonveterans. #Melanoma @linos_eleni
0
3
5